Crossmark

Efficacy and safety of combined therapy with synthetic disease-modifying antirheumatic drugs in rheumatoid arthritis: Systematic literature review

Crossref DOI link: https://doi.org/10.1016/j.reumae.2018.07.010

Published Print: 2020-09

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Calvo Alén, Jaime

Pérez, Trinidad

Romero Yuste, Susana

Ferraz-Amaro, Iván

Alegre Sancho, Juan José

Pinto Tasende, José Antonio

Maceiras Pan, Francisco

Quevedo, Juan Carlos

Hernández-Hernández, M. Vanesa

Hidalgo Calleja, Cristina

San Martín Álvarez, Alejandro

Tevar Sánchez, María Isabel

Sanmartí, Raimon
Funding

Funding for this research was provided by:

Roche
License Information

Text and Data Mining valid from 2020-09-01
More Information

This article is maintained by: Elsevier

Article Title: Efficacy and safety of combined therapy with synthetic disease-modifying antirheumatic drugs in rheumatoid arthritis: Systematic literature review

Journal Title: Reumatología Clínica (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.reumae.2018.07.010

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.reuma.2018.07.016

Content Type: article

Copyright: © 2018 Elsevier España, S.L.U. and Sociedad Española de Reumatología y Colegio Mexicano de Reumatología. All rights reserved.